Non-small cell lung cancer stage IIIA
Information
- Disease name
- Non-small cell lung cancer stage IIIA
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01991418 | Completed | Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC) | May 2013 | February 2016 | |
| NCT04455594 | Not yet recruiting | Phase 2 | Almonertinib Vs. Erlotinib/Chemotherapy for Neo-adjuVant Treatment of Stage IIIA-N2 EGFR-mutated NSCLC | October 2020 | October 2025 |
| NCT04716946 | Recruiting | Phase 2 | Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy | January 27, 2021 | February 2025 |
| NCT05732974 | Recruiting | A Machine Learning Approach to Identify Patients With Resected Non-small-cell Lung Cancer With High Risk of Relapse | March 30, 2023 | October 30, 2026 | |
| NCT06268613 | Recruiting | Phase 1 | A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy | January 16, 2024 | December 2025 |
| NCT02974426 | Terminated | Phase 3 | To Evaluate the Optimal Timing of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer | November 2016 | February 2024 |
| NCT02977169 | Unknown status | Phase 2 | To Evaluate the Role of Postoperative Radiotherapy in Patients With IIIA(N2) Non-Small Cell Lung Cancer | November 2016 | December 2021 |
| NCT01926483 | Unknown status | Phase 2 | Phase II Trial of Regimen for Stage III (N2) NSCLC Using Induction Treatment Followed by Resection | March 2013 | June 2016 |
| NCT01410214 | Unknown status | Phase 2 | Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations | May 2011 | July 2017 |